Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People treated with direct-acting antivirals had a lower risk for liver failure and liver cancer as well as much lower mortality.
Less than 10% of people with cirrhosis were regularly monitored for liver cancer.
However, some 10% experienced liver decompensation even after antiviral therapy.
Some experts have doubted the link between sustained virologic response and clinical outcomes.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.